Amylyx Pharmaceuticals, Inc.AMLXNASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
15.94%
↑ 106% above average
Average (19q)
-273.39%
Historical baseline
Range
High:1083.97%
Low:-6414.89%
Volatility
-2742.9%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 15.94% |
| Q2 2025 | -13.37% |
| Q1 2025 | 7.01% |
| Q4 2024 | 46.27% |
| Q3 2024 | -41.59% |
| Q2 2024 | 56.25% |
| Q1 2024 | -6414.89% |
| Q4 2023 | -89.67% |
| Q3 2023 | -7.33% |
| Q2 2023 | 1083.97% |
| Q1 2023 | 95.40% |
| Q4 2022 | 18.45% |
| Q3 2022 | -0.79% |
| Q2 2022 | -13.47% |
| Q1 2022 | -68.86% |
| Q4 2021 | -23.55% |
| Q3 2021 | -23.30% |
| Q2 2021 | -44.44% |
| Q1 2021 | -49.77% |
| Q4 2020 | 0.00% |